Related Experiment Video
Updated: Apr 30, 2026
10:04
Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
Published on: October 29, 2012
19.3K
Pyrilamine inhibits nicotine-induced catecholamine secretion
Dong-Chan Kim1, So Jeong Yun2, Yong-Soo Park3
1Division of Molecular and Life Science, System Bio-Dynamics, POSTECH, Pohang, Republic of Korea; Department of Biomedical Laboratory Science, Gimcheon University, Gimcheon 740-704, Republic of Korea; Division of Molecular and Life Science, POSTECH, Pohang, Republic of Korea; Laboratory of Microvascular Circulation Research, NEURONEX Inc., Goryung, Republic of Korea.
Neurochemistry International
|May 13, 2014
Summary
Pyrilamine directly binds to nicotinic acetylcholine receptors (nAChRs), inhibiting nicotine
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Research
Background:
- Nicotine's effects on the central nervous system are extensively studied.
- Understanding nicotine binding is crucial for smoking addiction therapy.
- Pyrilamine's interaction with nicotine receptors is not fully understood.
Purpose of the Study:
- To investigate the direct binding mechanisms of pyrilamine on nicotinic acetylcholine receptors (nAChRs).
- To clarify pyrilamine's interaction with nicotine binding target receptors.
Main Methods:
- Investigated pyrilamine's binding to nAChRs.
- Assessed catecholamine (CA) secretion inhibition by pyrilamine.
- Utilized real-time carbon-fiber amperometry for single-cell analysis.
- Measured intracellular calcium ([Ca(2+)]i) changes.
Main Results:
- Pyrilamine shares the nicotine binding pocket on nAChRs but interacts with more residues.
- Pyrilamine inhibits nicotine-induced catecholamine secretion and calcium influx.
- Pyrilamine's effects are specific to nAChR-mediated actions, not high K+-induced calcium increase.
Conclusions:
- Pyrilamine directly binds to nAChRs, inhibiting their function.
- Pyrilamine specifically blocks nAChR-mediated catecholamine secretion.
- Pyrilamine shows potential as a therapeutic agent for smoking cessation.
Related Concept Videos
01:23Drugs Acting on Autonomic Ganglia: Stimulants
2.2K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.2K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.8K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.8K
01:25Adrenergic Agonists: Indirect-Acting Agents
2.8K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.8K
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
2.3K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
2.3K
01:28Adrenergic Agonists: Mixed-Action Agents
1.7K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.7K
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.9K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K